Glenview Capital Management - Q4 2021 holdings

$4.69 Billion is the total value of Glenview Capital Management's 57 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 36.1% .

 Value Shares↓ Weighting
THC SellTENET HEALTHCARE CORP$598,551,000
+4.1%
7,327,108
-15.3%
12.76%
+22.3%
MCK SellMCKESSON CORP$382,761,000
+10.9%
1,539,852
-11.0%
8.16%
+30.3%
BHC SellBAUSCH HEALTH COS INC$345,184,000
-20.8%
12,502,147
-20.1%
7.36%
-6.9%
GPN BuyGLOBAL PMTS INC$282,209,000
+34.0%
2,087,657
+56.2%
6.01%
+57.5%
CI SellCIGNA CORP NEW$254,782,000
-3.8%
1,109,534
-16.1%
5.43%
+13.1%
BAX BuyBAXTER INTL INC$187,339,000
+7.4%
2,182,422
+0.7%
3.99%
+26.2%
DXC SellDXC TECHNOLOGY CO$160,756,000
-14.6%
4,993,958
-10.9%
3.43%
+0.3%
CCEP BuyCOCA-COLA EUROPACIFIC PARTNE$149,316,000
+23.0%
2,669,687
+21.6%
3.18%
+44.6%
ABC SellAMERISOURCEBERGEN CORP$137,181,000
-39.1%
1,032,288
-45.3%
2.92%
-28.5%
HCA SellHCA HEALTHCARE INC$123,137,000
-3.4%
479,280
-8.7%
2.62%
+13.5%
DD SellDUPONT DE NEMOURS INC$121,867,000
+17.7%
1,508,632
-0.9%
2.60%
+38.4%
CNC SellCENTENE CORP DEL$111,795,000
-15.5%
1,356,736
-36.1%
2.38%
-0.7%
CTVA BuyCORTEVA INC$107,825,000
+15.2%
2,280,562
+2.5%
2.30%
+35.3%
UBER BuyUBER TECHNOLOGIES INC$106,090,000
-2.7%
2,530,170
+4.0%
2.26%
+14.4%
UHS SellUNIVERSAL HLTH SVCS INCcl b$100,696,000
-17.2%
776,618
-11.7%
2.15%
-2.7%
APTV SellAPTIV PLC$88,960,000
-27.5%
539,317
-34.5%
1.90%
-14.8%
WLTW SellWILLIS TOWERS WATSON PLC LTD$86,208,000
-55.5%
362,996
-56.4%
1.84%
-47.7%
FMC SellFMC CORP$84,825,000
+20.0%
771,911
-0.0%
1.81%
+41.0%
MTOR BuyMERITOR INC$67,584,000
+142.3%
2,727,342
+108.3%
1.44%
+184.6%
AMZN NewAMAZON COM INC$64,603,00019,375
+100.0%
1.38%
DVA BuyDAVITA INC$60,593,000
+11.2%
532,638
+13.6%
1.29%
+30.7%
ESI SellELEMENT SOLUTIONS INC$56,903,000
-4.7%
2,343,601
-14.9%
1.21%
+12.1%
USFD NewUS FOODS HLDG CORP$56,394,0001,619,112
+100.0%
1.20%
BKD SellBROOKDALE SR LIVING INC$52,692,000
-37.8%
10,211,649
-24.1%
1.12%
-26.9%
FISV SellFISERV INC$51,813,000
-22.5%
499,206
-18.9%
1.10%
-8.9%
NSC SellNORFOLK SOUTHN CORP$51,564,000
-22.4%
173,203
-37.7%
1.10%
-8.8%
LGVU  LONGVIEW ACQUISITION CORP IIunit 99/99/9999$50,050,000
-1.3%
5,000,0000.0%1.07%
+16.1%
EHC BuyENCOMPASS HEALTH CORP$48,540,000
+61.4%
743,798
+85.6%
1.03%
+89.7%
CHNG SellCHANGE HEALTHCARE INC$47,695,000
-0.2%
2,230,811
-2.3%
1.02%
+17.2%
QSI  QUANTUM SI INC$47,220,000
-5.6%
6,000,0000.0%1.01%
+10.9%
BSX SellBOSTON SCIENTIFIC CORP$46,672,000
-47.9%
1,098,684
-46.8%
1.00%
-38.7%
MYGN SellMYRIAD GENETICS INC$46,361,000
-35.8%
1,679,747
-24.8%
0.99%
-24.5%
HOLX SellHOLOGIC INC$44,812,000
-13.3%
585,321
-16.4%
0.96%
+1.9%
UNP SellUNION PAC CORP$42,974,000
-33.5%
170,579
-48.2%
0.92%
-21.8%
NSP SellINSPERITY INC$40,472,000
-28.5%
342,664
-33.0%
0.86%
-16.1%
MCK  MCKESSON CORPcall$39,771,000
+24.7%
160,0000.0%0.85%
+46.5%
GOOGL SellALPHABET INCcap stk cl a$35,242,000
-73.8%
12,165
-75.8%
0.75%
-69.2%
GOOGL NewALPHABET INCput$34,764,00012,000
+100.0%
0.74%
SABR BuySABRE CORP$33,751,000
-23.1%
3,929,064
+6.0%
0.72%
-9.7%
BFLY  BUTTERFLY NETWORK INC$33,214,000
-35.9%
4,964,7510.0%0.71%
-24.7%
AMGN BuyAMGEN INC$30,291,000
+34.5%
134,645
+27.2%
0.65%
+58.3%
HUM SellHUMANA INC$25,502,000
-63.6%
54,978
-69.5%
0.54%
-57.2%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$21,751,000
+36.9%
157,835
+38.0%
0.46%
+61.1%
ATVI NewACTIVISION BLIZZARD INC$20,567,000309,132
+100.0%
0.44%
FLEX SellFLEX LTDord$18,330,000
-7.1%
1,000,000
-10.4%
0.39%
+9.2%
IS SellIRONSOURCE LTD$15,230,000
-66.1%
1,967,668
-52.4%
0.32%
-60.2%
DNB  DUN & BRADSTREET HLDGS INC$15,052,000
+21.9%
734,5950.0%0.32%
+43.3%
CHNG NewCHANGE HEALTHCARE INCcall$10,690,000500,000
+100.0%
0.23%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$9,835,00082,789
+100.0%
0.21%
ENDP SellENDO INTL PLC$8,201,000
-61.4%
2,181,239
-66.7%
0.18%
-54.5%
NewHYPERFINE INC$7,250,0001,000,000
+100.0%
0.16%
MRTX  MIRATI THERAPEUTICS INC$6,718,000
-17.1%
45,8000.0%0.14%
-2.7%
OUST  OUSTER INC$6,250,000
-29.0%
1,201,9820.0%0.13%
-16.9%
OHPAU SellORION ACQUISITION CORPunit 02/19/2026$4,777,000
-3.3%
485,001
-3.0%
0.10%
+13.3%
SellEVOLV TECHNOLOGIES HLDNGS IN$3,343,000
-34.5%
749,461
-11.8%
0.07%
-22.8%
DMRC NewDIGIMARC CORP NEW$2,961,00075,000
+100.0%
0.06%
EOLS NewEVOLUS INC$2,564,000393,827
+100.0%
0.06%
VELOW ExitVELOCITY ACQUISITION CORP*w exp 02/24/202$0-244,060
-100.0%
-0.00%
ATIPWS ExitATI PHYSICAL THERAPY INC*w exp 08/10/202$0-300,000
-100.0%
-0.00%
ATIP ExitATI PHYSICAL THERAPY INC$0-249,145
-100.0%
-0.02%
BOWX ExitBOWX ACQUISITION CORPcl a$0-757,294
-100.0%
-0.14%
FST ExitFAST ACQUISITION CORP$0-878,761
-100.0%
-0.20%
OGN ExitORGANON & CO$0-753,127
-100.0%
-0.45%
ExitCCC INTELLIGENT SOLUTIONS HL$0-2,405,960
-100.0%
-0.46%
V ExitVISA INC$0-134,630
-100.0%
-0.54%
ANTM ExitANTHEM INC$0-88,011
-100.0%
-0.60%
FB ExitFACEBOOK INCcl a$0-205,401
-100.0%
-1.26%
MOH ExitMOLINA HEALTHCARE INC$0-330,105
-100.0%
-1.62%
VIAC ExitVIACOMCBS INCcl b$0-2,667,822
-100.0%
-1.91%
TAK ExitTAKEDA PHARMACEUTICAL CO LTDsponsored ads$0-8,102,119
-100.0%
-2.41%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

About Glenview Capital Management

Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.

Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.

Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.

Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENET HEALTHCARE CORP42Q3 202316.7%
HCA HOLDINGS INC42Q3 20239.1%
MCKESSON CORP40Q3 20238.2%
FLEXTRONICS INTL LTD38Q2 20234.5%
BROOKDALE SR LIVING INC38Q3 20232.1%
MERITOR INC36Q1 20223.0%
FMC CORP34Q2 20236.4%
UNIVERSAL HLTH SVCS INC34Q3 20235.0%
HUMANA INC31Q4 202112.1%
ENDO INTL PLC30Q1 20222.8%

View Glenview Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Glenview Capital Management Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Butterfly Network, Inc.February 14, 20239,746,8345.5%
Quantum-Si IncFebruary 14, 20234,249,9563.6%
MERITOR, INC.February 22, 20223,544,3335.0%
ATI Physical Therapy, Inc.Sold outFebruary 14, 202200.0%
Evolv Technologies Holdings, Inc.February 14, 2022749,4610.5%
Velocity Acquisition Corp.Sold outFebruary 14, 202200.0%
Bausch Health Companies Inc.December 13, 202117,078,6574.8%
NewHold Investment Corp.June 04, 20211,114,8626.5%
Longview Acquisition Corp. IIApril 02, 20215,000,0007.2%
HighCape Capital Acquisition Corp.March 15, 20211,033,7398.7%

View Glenview Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-16
13F-HR2023-11-14
SC 13G2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15

View Glenview Capital Management's complete filings history.

Compare quarters

Export Glenview Capital Management's holdings